Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
10.1038/35074506
Crossref journal-article
Springer Science and Business Media LLC
Nature Cell Biology (297)
Bibliography

Llanos, S., Clark, P. A., Rowe, J., & Peters, G. (2001). Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nature Cell Biology, 3(5), 445–452.

Authors 4
  1. Susana Llanos (first)
  2. Paula A. Clark (additional)
  3. Janice Rowe (additional)
  4. Gordon Peters (additional)
References 38 Referenced 196
  1. Ruas, M. & Peters, G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378, 115–177 (1998). / Biochim. Biophys. Acta by M Ruas (1998)
  2. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2991 (1998). (10.1101/gad.12.19.2984) / Genes Dev. by CJ Sherr (1998)
  3. Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999). (10.1101/gad.13.12.1501) / Genes Dev. by CJ Sherr (1999)
  4. James, M. C. & Peters, G. Alternative product of the p16/CDKN2A locus connects the Rb and p53 tumor suppressors. Prog. Cell Cycle Res. 4, 71–81 (2000). (10.1007/978-1-4615-4253-7_7) / Prog. Cell Cycle Res. by MC James (2000)
  5. Sharpless, N. E. & DePinho, R. A. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9, 22–30 (1999). (10.1016/S0959-437X(99)80004-5) / Curr. Opin. Genet. Dev. by NE Sharpless (1999)
  6. Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292–8297 (1998). (10.1073/pnas.95.14.8292) / Proc. Natl Acad. Sci. USA by T Kamijo (1998)
  7. Pomerantz, J. et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713–723 (1998). (10.1016/S0092-8674(00)81400-2) / Cell by J Pomerantz (1998)
  8. Stott, F. J. et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001–5014 (1998). (10.1093/emboj/17.17.5001) / EMBO J. by FJ Stott (1998)
  9. Zhang, Y., Xiong, Y. & Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53:ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725–734 (1998). (10.1016/S0092-8674(00)81401-4) / Cell by Y Zhang (1998)
  10. Honda, R. & Yasuda, H. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumour suppressor p53. EMBO J. 18, 22–27 (1999). (10.1093/emboj/18.1.22) / EMBO J. by R Honda (1999)
  11. Midgley, C. A. et al. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19, 2312–2323 (2000). (10.1038/sj.onc.1203593) / Oncogene by CA Midgley (2000)
  12. DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control. Proc. Natl Acad. Sci. USA 94, 7245–7250 (1997). (10.1073/pnas.94.14.7245) / Proc. Natl Acad. Sci. USA by J DeGregori (1997)
  13. Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124–125 (1998). (10.1038/25867) / Nature by S Bates (1998)
  14. Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G. & Vousden, K. H. Contribution of two independent MDM2-binding domains in p14ARF to p53 stabilization. Curr. Biol. 10, 539–542 (2000). (10.1016/S0960-9822(00)00472-3) / Curr. Biol. by MAE Lohrum (2000)
  15. Weber, J. D. et al. Cooperative signals governing ARF-MDM2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20, 2517–2528 (2000). (10.1128/MCB.20.7.2517-2528.2000) / Mol. Cell. Biol. by JD Weber (2000)
  16. Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993–1000 (1995). (10.1016/0092-8674(95)90214-7) / Cell by DE Quelle (1995)
  17. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20–26 (1999). (10.1038/8991) / Nature Cell Biol. by JD Weber (1999)
  18. Zhang, Y. & Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3, 579–591 (1999). (10.1016/S1097-2765(00)80351-2) / Mol. Cell by Y Zhang (1999)
  19. Lindström, M. S. et al. Immunolocalization of human p14ARF to the granular component of the interphase nucleus. Exp. Cell Res. 256, 400–410 (2000). (10.1006/excr.2000.4854) / Exp. Cell Res. by MS Lindström (2000)
  20. Rizos, H., Darmanian, A. P., Mann, G. J. & Kefford, R. F. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene 19, 2978–2985 (2000). (10.1038/sj.onc.1203629) / Oncogene by H Rizos (2000)
  21. Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T. & Levine, A. J. Nucleo–cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554–564 (1998). (10.1093/emboj/17.2.554) / EMBO J. by J Roth (1998)
  22. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288–7293 (1998). (10.1128/MCB.18.12.7288) / Mol. Cell. Biol. by DA Freedman (1998)
  23. Tao, W. & Levine, A. J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl Acad. Sci. USA 96, 3077–3080 (1999). (10.1073/pnas.96.6.3077) / Proc. Natl Acad. Sci. USA by W Tao (1999)
  24. Tao, W. & Levine, A. J. p19ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl Acad. Sci. USA 96, 6937–6941 (1999). (10.1073/pnas.96.12.6937) / Proc. Natl Acad. Sci. USA by W Tao (1999)
  25. Diller, L. et al. p53 functions as a cell cycle control point in osteosarcoma. Mol. Cell. Biol. 10, 5772–5781 (1990). (10.1128/MCB.10.11.5772) / Mol. Cell. Biol. by L Diller (1990)
  26. Dimri, G. P., Itahana, K., Acosta, M. & Campisi, J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol. Cell. Biol. 20, 273–285 (2000). (10.1128/MCB.20.1.273-285.2000) / Mol. Cell. Biol. by GP Dimri (2000)
  27. Kurokawa, K., Tanaka, T. & Kato, J. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts. Oncogene 18, 2718–2727 (1999). (10.1038/sj.onc.1202628) / Oncogene by K Kurokawa (1999)
  28. Ochs, R. L. Methods used to study structure and function of the nucleolus. Methods Cell Biol. 53, 303–321 (1998). (10.1016/S0091-679X(08)60884-5) / Methods Cell Biol. by RL Ochs (1998)
  29. Quelle, D. E., Cheng, M., Ashmun, R. A. & Sherr, C. J. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc. Natl Acad. Sci. USA 94, 669–673 (1997). (10.1073/pnas.94.2.669) / Proc. Natl Acad. Sci. USA by DE Quelle (1997)
  30. Johnston, J. A., Ward, C. L. & Kopito, R. R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883–1898 (1998). (10.1083/jcb.143.7.1883) / J. Cell Biol. by JA Johnston (1998)
  31. García-Mata, R., Bebök, Z., Sorscher, E. J. & Sztul, E. S. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146, 1239–1254 (1999). (10.1083/jcb.146.6.1239) / J. Cell Biol. by R García-Mata (1999)
  32. Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660–1672 (1999). (10.1093/emboj/18.6.1660) / EMBO J. by JM Stommel (1999)
  33. Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G. & Vousden, K. H. Identification of a cryptic nucleolar-localization signal in MDM2. Nature Cell Biol. 2, 179–181 (2000). (10.1038/35004057) / Nature Cell Biol. by MAE Lohrum (2000)
  34. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J-C. & Levine, A. J. The ribosomal L5 protein is associated with mdm-2 and mdm-2–p53 complexes. Mol. Cell. Biol. 14, 7414–7420 (1994). (10.1128/MCB.14.11.7414) / Mol. Cell. Biol. by V Marechal (1994)
  35. McConnell, B. B., Starborg, M., Brookes, S. & Peters, G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8, 351–354 (1998). (10.1016/S0960-9822(98)70137-X) / Curr. Biol. by BB McConnell (1998)
  36. Dalton, S. & Treisman, R. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68, 597–612 (1992). (10.1016/0092-8674(92)90194-H) / Cell by S Dalton (1992)
  37. Bates, S. et al. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 9, 71–79 (1994). / Oncogene by S Bates (1994)
  38. Kubbutat, M. H. G., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 287, 299–303 (1997). (10.1038/387299a0) / Nature by MHG Kubbutat (1997)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:43 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 4:04 p.m.)
Indexed 5 days, 22 hours ago (Aug. 19, 2025, 6:02 a.m.)
Issued 24 years, 4 months ago (April 5, 2001)
Published 24 years, 4 months ago (April 5, 2001)
Published Online 24 years, 4 months ago (April 5, 2001)
Published Print 24 years, 3 months ago (May 1, 2001)
Funders 0

None

@article{Llanos_2001, title={Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus}, volume={3}, ISSN={1476-4679}, url={http://dx.doi.org/10.1038/35074506}, DOI={10.1038/35074506}, number={5}, journal={Nature Cell Biology}, publisher={Springer Science and Business Media LLC}, author={Llanos, Susana and Clark, Paula A. and Rowe, Janice and Peters, Gordon}, year={2001}, month=apr, pages={445–452} }